IP Library Granted Patent US 9,737,519
Granted Patent B2
US 9,737,519 · App. 15/083,349 · Granted Aug 22, 2017

Compositions and methods for enhancing brain function

Inventor: Josh Reynolds (Laguna Beach, CA)
Assignee: KeyView Labs, Inc.
A61K31/439A23L33/105A23L33/175A23L33/21A61K9/0053A61K9/28A61K9/50A61K31/19A61K31/197A61K31/205A61K31/22A61K31/221A61K31/385A61K31/4188A61K31/4375A61K31/473A61K31/4748A61K36/41A61K45/06A23V2002/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,737,519
App. No.
15/083,349
Granted
Aug 22, 2017
Kind
B2
Abstract

Compositions and methods are provided that enhance cognition in a human to which the composition is orally administered. Remarkably, clinical studies have proven that contemplated compositions achieved the desired effects using a minimal number of active ingredients at or near threshold active dosages, wherein such compositions almost exclusively comprise huperzine A, vinpocetine or rhodiola , and acetyl-L-carnitine, and optionally further include alpha lipoic acid, rhodiola , and biotin.

Claims (15)

1. A nutritional supplement composition for enhancing cognitive function, comprising:

huperzine A;

vinpocetine and rhodiola ; and

acetyl-L-carnitine;

wherein the composition is formulated for oral administration and the vinpocetine is present in an amount from about 10 mg to 30 mg and the rhodiola is present in an amount from about 200 mg to about 400 mg, and the acetyl-L-carnitine is present in an amount from about 1,250 mg to 2000 mg, and the huperzine A, acetyl-L-carnitine, and vinpocetine and rhodiola together account for at least 80 wt % of a dosage unit of the composition.

2. The nutritional supplement composition of claim 1 , further comprising alpha lipoic acid in an amount of about 300 mg to about 500 mg.

3. The nutritional supplement composition of claim 1 , further comprising biotin in an amount of about 400 mcg to about 600 mcg.

4. The nutritional supplement composition of claim 1 , wherein the huperzine A is present in an amount from about 50 mcg to about 200 mcg.

5. The nutritional supplement composition of claim 1 , wherein the composition is formulated with an enteric coating.

6. The nutritional supplement composition of claim 1 , further comprising an inactive ingredient selected from the group consisting of a carrier, a binder, an excipient, a dye, and combinations thereof.

7. The nutritional supplement composition of claim 1 , wherein the huperzine A, vinpocetine and rhodiola , and the acetyl-L-carnitine together account for at least 90 wt % of a dosage unit of the composition.

8. The nutritional supplement composition of claim 1 , wherein the huperzine A, vinpocetine and rhodiola , and the acetyl-L-carnitine together account for at least 95 wt % of the dosage unit of the composition.

9. The nutritional supplement composition of claim 1 , wherein the dosage unit of the composition is equal or less than 1,200 mg.

10. The nutritional supplement composition of claim 1 , wherein the huperzine A, vinpocetine and rhodiola , and the acetyl-L-carnitine are in a ratio of a:b:c:d respectively, wherein a is between about 0.8 and about 1.2 for huperzine A, b is between about 80 and about 120 for vinpocetine, c is between about 1,600 and about 2,400 for rhodiola , and d is between about 8,000 and about 12,000 for acetyl-L-carnitine.

11. The nutritional supplement composition of claim 10 , wherein a is between about 0.9 and about 1.1 for huperzine A, b is between about 90 and about 110 for vinpocetine, c is between about 1,800 and about 2,200 for rhodiola , and d is between about 9,000 and about 11,000 for acetyl-L-carnitine.

Assignments (1)
SECURITY INTEREST Recorded Jun 21, 2017
From: KEYVIEW LABS, INC.
To: PACIFIC WESTERN BANK, AS SUCCESSOR IN INTEREST BY MERGER TO SQUARE 1 BANK
Reel/Frame 042769/0690 →
Continuity (6)
Continuation 14499457 · Sep 29, 2014
Continuation 13307587 · Nov 30, 2011
Continuation In Part 11758151 · Jun 5, 2007
Provisional Application 60803943 · Jun 5, 2006
Provisional Application 60820201 · Jul 24, 2006
Related Publication 20160206602A1 · Jul 21, 2016